Shozeb Haider

9.4k citations

141 papers · 4.7k indexed · h-index 37

Impact in

Molecular Biology top 2%
- DNA and Nucleic Acid Chemistry
- Advanced biosensing and bioanalysis techniques
- RNA Interference and Gene Delivery
- RNA and protein synthesis mechanisms
- Ion channel regulation and function
- Protein Structure and Dynamics
Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria

Papers in

Molecular Medicine 14
- Antibiotic Resistance in Bacteria 14
Molecular Biology 106
- DNA and Nucleic Acid Chemistry 47
- Advanced biosensing and bioanalysis techniques 47
- RNA Interference and Gene Delivery 33
- Ion channel regulation and function 14
- RNA and protein synthesis mechanisms 10
- Protein Structure and Dynamics 8

Co-authors: Stephen Neidle Gary N. Parkinson Mark S.P. Sansom Frances M. Ashcroft Barira Islam Mekala Gunaratnam Gavin W. Collie Peter Proks
Journals: eLife (10 papers)Nucleic Acids Research (8 papers)Chemical Communications (6 papers)Scientific Reports (5 papers)Biochemistry (5 papers)
Partner nations: United Kingdom United States Italy

In The Last Decade

Shozeb Haider

128 papers receiving 4.7k citations

Peers

Countries citing papers authored by Shozeb Haider

Since Specialization

Citations

This map shows the geographic impact of Shozeb Haider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shozeb Haider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shozeb Haider more than expected).

Fields of papers citing papers by Shozeb Haider

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shozeb Haider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shozeb Haider. The network helps show where Shozeb Haider may publish in the future.

Co-authors

The 25 scholars most cited alongside Shozeb Haider, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shozeb Haider Line = papers co-authored together Shozeb Haider links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	DNA-Programmable Protein Degradation: Dynamic Control of Proteolysis-Targeting Chimera Activity via DNA Hybridization and Strand Displacement JACS Au ·Bongani Ngwenya -, Shozeb Haider, Thomas A. Milne, Michael J. Booth	2025	0
2	Selective molecular inhibition of the HDAC6 ZnF-UBP binding domain impairs multiple myeloma cell function Cell Death Discovery ·Sueng Jung Yoo, ดวงจิต เรืองกฤษณ์, Muliyani, Cheran Elangovan, 小橋吉博, Shozeb Haider, Carole Bourquin, Philìppe Bertrand, Muriel Cuendet	2025	0
3	SAND: a comprehensive annotation of class D β-lactamases using structural alignment-based numbering Antimicrobial Agents and Chemotherapy ·Aulia Putri Fadriyana, 吉展金沢, James Spencer, Bogdan I. Iorga, Jean‐Denis Docquier, Gian María Rossolini, Mariagrazia Perilli, Gianfranco Amicosante, Alejandro J. Vila, Sergei B. Vakulenko, Shahriar Mobashery, Patricia A. Bradford, Karen Bush, Sally R. Partridge, Andrea M. Hujer, Dillon F. Rudman, Robert A. Bonomo, Shozeb Haider	2025	2
4	Evolutionary Dynamics and Functional Differences in Clinically Relevant Pen β-Lactamases from Burkholderia spp. Journal of Chemical Information and Modeling ·Jing Gu, Pratul K. Agarwal, Robert A. Bonomo, Shozeb Haider	2025	0
5	Structure–activity relationships for the G-quadruplex-targeting experimental drug QN-302 and two analogues probed with comparative transcriptome profiling and molecular modeling Scientific Reports ·Ahmed A. Ahmed, Shuang Chen, E. Braun, Richard Angell, Sally Oxenford, Gc. Black, T Ramaroson, Sarah Elizabeth Kabler, Brian E. Compas, Shozeb Haider, D. Naylor and P.M. Shannon, Stephen Neidle	2024	22
6	Exploiting functional regions in the viral RNA genome as druggable entities eLife ·Dehua Luo, Klaudia Sobczak, Zhiyuan Huang, VL Somwanshi, José Enrique Teixeira Reinoso, Shiunsuke Ishiwara, Qingling Li, Yuqing Bai, Shozeb Haider, Dengguo Wei	2024	1
7	Emerging variants of SARS-CoV-2 NSP10 highlight strong functional conservation of its binding to two non-structural proteins, NSP14 and NSP16 eLife ·Huan Wang, Shotaro Kubota, Congli Fang, SELENE DIAS NUNES, Tiago André Nunes Teixeira, 宮本憲一, Yufeng Su, Fares Z. Najar, Pratul K. Agarwal, Frank Kozielski, Shozeb Haider	2023	10
8	Natural protein engineering in the Ω-loop: the role of Y221 in ceftazidime and ceftolozane resistance in Pseudomonas -derived cephalosporinase Antimicrobial Agents and Chemotherapy ·Andrew R Mack, Vijay Kumar, Magdalena A. Taracila, María F. Mojica, Margaret O’Shea, Yeong‐Chang Ou, Charles B Atkinson, Andrea M. Hujer, Krisztina M. Papp‐Wallace, Shuang Chen, Shozeb Haider, Emilia Caselli, Fabio Prati, Focco van den Akker, Robert A. Bonomo	2023	8
9	Control of cell surface expression of GABAA receptors by a conserved region at the end of the N-terminal extracellular domain of receptor subunits Journal of Biological Chemistry ·J. Hakim, Debra Rybski, Philip Long, Zhihan Xu, F. Anne Stephenson, Shozeb Haider, Jasmina N. Jovanovic	2022	2
10	In Vivo Investigation of (2-Hydroxypropyl)-β-cyclodextrin-Based Formulation of Spironolactone in Aqueous Solution for Paediatric Use Pharmaceutics ·Antonio Lopalco, Rafael de Paz Sánchez, 真藤城, Shozeb Haider, Mikel Gorriti, Angela Lopedota, Cosimo Altomare, Nunzio Denora, Catherine Tuleu	2022	11
11	Triazole-substituted phenylboronic acids as tunable lead inhibitors of KPC-2 antibiotic resistance European Journal of Medicinal Chemistry ·Jingyuan Zhou, Paul Stapleton, Francisco Humberto Xavier Júnior, Andreas G. Schätzlein, Shozeb Haider, Jess Healy, Geoffrey Wells	2022	5
12	Two Ligand-Binding Sites on SARS-CoV-2 Non-Structural Protein 1 Revealed by Fragment-Based X-ray Screening International Journal of Molecular Sciences ·BaoHan Pan, Willa A. Decker, SELENE DIAS NUNES, Nikos Pinotsis, Matthew W. Bowler, Shozeb Haider, Frank Kozielski	2022	17
13	Beyond bone biology: Lessons from team science Journal of Orthopaedic Research® ·Mone Zaidi, Daria Lizneva, Sakshi Gera, Younhee Jeong, Funda Korkmaz, Anisa Gumerova, Kseniia Ievleva, Naseer Ahmad, Vitaly Ryu, Li Sun, Se‐Min Kim, Maria I. New, Shozeb Haider, Jameel Iqbal, Clifford J. Rosen, Tony Yuen	2020	0
14	Native de novo structural determinations of non-canonical nucleic acid motifs by X-ray crystallography at long wavelengths Nucleic Acids Research ·浩仁大岡, Kamel El Omari, Ramona Duman, Sisi Liu, Shozeb Haider, Armin Wagner, Gary N. Parkinson, Dengguo Wei	2020	10
15	Is the Fate of Clinical Candidate Arry-520 Already Sealed? Predicting Resistance in Eg5–Inhibitor Complexes Molecular Cancer Therapeutics ·黃木誼, Sandeep K. Talapatra, F. Amin, Shozeb Haider, Simon P. Mackay, Frank Kozielski, Dimitrios A. Skoufias	2019	14
16	The Highly Recurrent PP2A Aα-Subunit Mutation P179R Alters Protein Structure and Impairs PP2A Enzyme Function to Promote Endometrial Tumorigenesis Cancer Research ·Sarah E. Taylor, Caitlin M. O’Connor, Zhizhi Wang, Guobo Shen, 岡本貴隆, Daniel Léonard, Jaya Sangodkar, Elmer Daniel Tejada Velásquez, Stefanie Avril, Steven Waggoner, Kristine Zanotti, Amy J. Armstrong, Christa Nagel, Kimberly Resnick, Sareena Singh, Mark W. Jackson, Wenqing Xu, Shozeb Haider, Analisa DiFeo, Goutham Narla	2019	42
17	Inactivation of PP2A by a recurrent mutation drives resistance to MEK inhibitors Oncogene ·Caitlin M. O’Connor, Daniel Léonard, Danica Wiredja, Rita A. Avelar, Zhizhi Wang, Daniela Schlatzer, Benjamin L. Bryson, Е Ю Итыгилова, Sarah E. Taylor, Aditya Upadhyay, Jaya Sangodkar, Anne‐Claude Gingras, Jukka Westermarck, Wenqing Xu, Analisa DiFeo, David L. Brautigan, Shozeb Haider, Mark W. Jackson, Goutham Narla	2019	27
18	Selective recognition ofc-MYCPu22 G-quadruplex by a fluorescent probe Nucleic Acids Research ·Qianqian Zhai, Chao Gao, Franck Nguyen, 浩仁大岡, Barira Islam, Wenxian Lan, A. MAZAS, Akifuddin, Jun Li, Zhe Hu, 伶佳杉田, Sheng‐Zhen Xu, Chunyang Cao, Shozeb Haider, Dengguo Wei	2019	74
19	Carbazole Derivatives’ Binding to c-KIT G-Quadruplex DNA Molecules ·Agata Głuszyńska, Bernard Juskowiak, Syaila Rizky Amanda, Marcin Hoffmann, Shozeb Haider	2018	23
20	Targeting telomerase and telomeres: a click chemistry approach towards highly selective G-quadruplex ligands Molecular BioSystems ·Adam D. Moorhouse, Shozeb Haider, Mekala Gunaratnam, Deeksha Munnur, Stephen Neidle, John E. Moses	2008	33

About Shozeb Haider

Shozeb Haider is a scholar working on Molecular Medicine, Molecular Biology, Endocrinology, Infectious Diseases and Computational Theory and Mathematics, having authored 141 papers that have together received 4.7k indexed citations. Recurring topics across this work include DNA and Nucleic Acid Chemistry (47 papers), Advanced biosensing and bioanalysis techniques (47 papers), RNA Interference and Gene Delivery (33 papers), Antibiotic Resistance in Bacteria (14 papers), Ion channel regulation and function (14 papers), RNA and protein synthesis mechanisms (10 papers), Protein Structure and Dynamics (8 papers) and Computational Drug Discovery Methods (8 papers). The work is most often cited by research in Molecular Biology (3.7k citations), Molecular Medicine (181 citations), Toxicology (57 citations), Endocrinology, Diabetes and Metabolism (217 citations) and Applied Microbiology and Biotechnology (25 citations). Shozeb Haider has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Stephen Neidle, Gary N. Parkinson, Mark S.P. Sansom, Frances M. Ashcroft, Barira Islam, Mekala Gunaratnam, Gavin W. Collie, Peter Proks, Jiřı́ Šponer and Jennifer F. Antcliff. Their work appears in journals such as eLife, Nucleic Acids Research, Chemical Communications, Scientific Reports and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact